Gevokizumab [1129435-60-4]

TargetMol Chemicals

Gevokizumab

9

1129435-60-4

Antibody

Research Use Only

Gevokizumab

Gevokizumab, a powerful anti-IL-1beta antibody, inhibits IL-1beta signaling allosterically, effectively reducing IL-1betas binding affinity for its IL-1 receptor type I (IL-1RI) signaling receptor, while not affecting its interaction with the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II) [1] [2].

3 years

-20°C

12352203